title: Modifying the Poor Prognosis Associated with 18F-FDG-Avid NET with Peptide Receptor Chemo-Radionuclide Therapy (PRCRT).
authors: Peter MacCallum Cancer Centre St. Andrews Place East Melbourne 3002, Australia E-mail: michael.hofman@petermac.org.
authors: Michael S
authors: MS
authors: Hofman
authors: Peter MacCallum Cancer Centre St. Andrews Place East Melbourne 3002, Australia E-mail: michael.hofman@petermac.org.
authors: Michael
authors: M
authors: Michael
authors: Peter MacCallum Cancer Centre St. Andrews Place East Melbourne 3002, Australia E-mail: michael.hofman@petermac.org.
authors: Raghava
authors: R
authors: Kashyap
authors: Peter MacCallum Cancer Centre St. Andrews Place East Melbourne 3002, Australia E-mail: michael.hofman@petermac.org.
authors: Rodney J
authors: RJ
authors: Hicks
mesh_terms: D005260:Female; D019788:Fluorodeoxyglucose F18; D006801:Humans; D007414:Intestinal Neoplasms / Q000000981:diagnostic imaging*; D008297:Male; D018358:Neuroendocrine Tumors / Q000000981:diagnostic imaging*; D010190:Pancreatic Neoplasms / Q000000981:diagnostic imaging*; D049268:Positron-Emission Tomography; D013274:Stomach Neoplasms / Q000000981:diagnostic imaging*
chemical_list: D019788:Fluorodeoxyglucose F18